Chromium in carcinogenesis and angiogenesis
Chromium in carcinogenesis and angiogenesis
批准号:
10328704
负责人:
BingHua Jiang
金额:
$30.78万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-06-30
中文摘要
六价铬[Cr(VI)]长期暴露与人类肺癌有关。尽管有
英文摘要
Hexavalent chromium [Cr(VI)] long-term exposure is associated with human lung cancer. Although there is
emerging interest in the mechanism underlying Cr(VI)-induced carcinogenesis, the mechanism and role of
Cr(VI) in inducing carcinogenesis still remains to be elucidated. In preliminary studies, we used human
peripheral blood mononuclear cells (PBMC cells) from Cr(VI) exposed and control subjects to perform whole
genome expression array analysis, and found that IL-8 and CXCL5 are the two most up-regulated genes
detected in the exposure group compared with non-exposure subjects. We validated our findings by RT-qPCR
and ELISA assay. Additionally, we found that miR-199a suppression and β-catenin upregulation are important
for IL-8 and CXCL5 induction. Forced expression of miR-199a and knockdown of IL-8 or CXCL5 inhibited both
cell transformation and angiogenesis. These findings are consistent with our results obtained from Cr(VI)-
transformed cells and from in vitro studies. Furthermore, we found that β-catenin directly activated IL-8
expression at transcriptional level, while miR-199a directly targets hypoxia-inducible factor 1
(HIF-1) for inhibiting HIF-1 expression. We hypothesize that miR-199a suppression and β-catenin
upregulation are important in Cr(VI)-induced tumorigenesis and angiogenesis through induction of IL-
8 and CXCL5 expression. Tumor cell growth and angiogenesis are the important characteristics of
carcinogenesis, transformation from normal cells to cancer cells. In order to test this hypothesis, we will
perform three specific aims: Aim 1) To determine role of miR-199a suppression and β-catenin upregulation in
Cr(VI)-induced cell transformation, and identify the mechanism of IL-8 and CXCL5 elevation. Aim 2) To
determine roles of miR-199a, β-catenin, IL-8, and CXCL5 in Cr(VI) transformed cell-induced tumor growth. Aim
3) To determine whether Cr-T cells induce tumor angiogenesis through IL-8 receptors using chimeric tumor
model and determine expression levels of IL-8, CXCL5, β-catenin, and miR-199a in peripheral blood
mononuclear cells (PBMCs) and plasma, and the possible correlations with Cr(VI) internal exposure doses in
workers with occupational Cr(VI) exposure. We will use a combination of molecular approaches, a n animal
model, and blood and tissue samples from human subjects to define roles and mechanisms of miR-199a, β-
catenin, IL-8, and CXCL5 in Cr(VI)-induced cell transformation, tumor growth, and angiogenesis. These
studies will not only help us understand the underlying mechanisms of Cr(VI) in inducing carcinogenesis, but
also identify potential new biomarkers for early detection of Cr(VI) exposure of workers in electroplating
factories in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatments
-
批准号:10303868
-
项目类别:
-
资助金额:$56.96万
-
财政年份:2018
-
负责人:BingHua Jiang
-
依托单位:
Chromium in carcinogenesis and angiogenesis
-
批准号:9980376
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:BingHua Jiang
-
依托单位:
NOX4 mediates oxidative stress in ovarian tumor growth and treatment response
-
批准号:9187916
-
项目类别:
-
资助金额:$10.6万
-
财政年份:2015
-
负责人:BingHua Jiang
-
依托单位:
Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer
-
批准号:8919299
-
项目类别:
-
资助金额:$16.97万
-
财政年份:2014
-
负责人:BingHua Jiang
-
依托单位:
Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer
-
批准号:8692266
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2014
-
负责人:BingHua Jiang
-
依托单位:
Molecular Mechanism of Arsenic Carcinogenesis
-
批准号:8632516
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2013
-
负责人:BingHua Jiang
-
依托单位:
Molecular Mechanism of Arsenic Carcinogenesis
-
批准号:9301706
-
项目类别:
-
资助金额:$4.01万
-
财政年份:2013
-
负责人:BingHua Jiang
-
依托单位:
Molecular Mechanism of Arsenic Carcinogenesis
-
批准号:9185317
-
项目类别:
-
资助金额:$32.94万
-
财政年份:2013
-
负责人:BingHua Jiang
-
依托单位:
WC-Co nanoparticles in initiating angiogenesis by reactive oxygen species
-
批准号:7851049
-
项目类别:
-
资助金额:$40.74万
-
财政年份:2009
-
负责人:BingHua Jiang
-
依托单位:
WC-Co nanoparticles in initiating angiogenesis by reactive oxygen species
-
批准号:7362918
-
项目类别:
-
资助金额:$42.49万
-
财政年份:2009
-
负责人:BingHua Jiang
-
依托单位:
Analysis of arsenic in inducing ROS, signaling pathways, and lung carcinogenesis
-
批准号:7630298
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2009
-
负责人:BingHua Jiang
-
依托单位:
Analysis of arsenic in inducing ROS, signaling pathways, and lung carcinogenesis
-
批准号:8130216
-
项目类别:
-
资助金额:$23.2万
-
财政年份:2009
-
负责人:BingHua Jiang
-
依托单位:
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis
-
批准号:7848456
-
项目类别:
-
资助金额:$2.22万
-
财政年份:2009
-
负责人:BingHua Jiang
-
依托单位:
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis
-
批准号:7340170
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2006
-
负责人:BingHua Jiang
-
依托单位:
Analysis of Apigenin in Inhibiting Ovarian Tumorigenesis
-
批准号:7151564
-
项目类别:
-
资助金额:$7.33万
-
财政年份:2006
-
负责人:BingHua Jiang
-
依托单位:
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis
-
批准号:7554659
-
项目类别:
-
资助金额:$22.72万
-
财政年份:2006
-
负责人:BingHua Jiang
-
依托单位:
Analysis of Apigenin in Inhibiting Ovarian Tumorigenesis
-
批准号:7260301
-
项目类别:
-
资助金额:$7.11万
-
财政年份:2006
-
负责人:BingHua Jiang
-
依托单位:
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis
-
批准号:7037741
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2006
-
负责人:BingHua Jiang
-
依托单位:
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis
-
批准号:8202732
-
项目类别:
-
资助金额:$4.08万
-
财政年份:2006
-
负责人:BingHua Jiang
-
依托单位:
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis
-
批准号:7175406
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2006
-
负责人:BingHua Jiang
-
依托单位:
国内基金
海外基金
RKTG对ERK信号通路的调控和肿瘤生成的影响
-
批准号:30830037
-
项目类别:重点项目
-
资助金额:190.0万元
-
批准年份:2008
-
负责人:陈雁
-
依托单位: